소개

이 페이지에서는 Reshma Kewalramani의 공개된 내부자의 매매 거래 내역을 종합적으로 분석합니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다. 이러한 제한에도 불구하고, 학계 연구에 따르면 내부자는, 일반적으로, 자신의 회사 주식에 대한 실적이 시장의 수익률을 능가하는 경향성을 보였습니다.

평균 거래 수익성

평균 거래 수익성은 내부자가 지난 3년 동안 매입한 모든 "공개 시장"(Open market)에서의 매입의 평균 수익률입니다. 이를 계산하기 위해 10b5-1 거래 계획의 일부로 표시된 모든 거래를 제외하고 내부자가 계획되지 않은 모든 오픈 마켓에서의 매입을 조사합니다. 그런 다음 3개월, 6개월, 12개월 동안 해당 거래의 평균 성과를 계산하여 각 거래에 대한 최종 성과 지표를 생성합니다. 마지막으로 내부자에 대한 성과 지표를 계산하기 위해 모든 성과 지표의 평균을 내립니다. 이 목록에는 지난 2년 동안 최소 3번 이상 거래한 내부자만 포함됩니다.

내부자의 매매 거래 수익성이 "해당 없음"인 경우, 내부자는 지난 3년 동안 공개 시장에서 매수한 적이 없거나, 거래가 너무 최근에 이루어져서 신뢰할 수 있는 성과 지표를 산출할 수 없는 경우에 해당합니다.

업데이트 주기: 일별

최고 수익율의 내부자 목록을 확인하세요.

내부자 포지션이 보고된 기업

SEC 서류에 따르면 Reshma Kewalramani 기업이 다음 기업에 대한 보유 또는 거래를 보고했습니다:

증권 소유권 최근 보고된 보유 주식
US:VRTX / Vertex Pharmaceuticals Incorporated CEO & President, Director 98,278
Director 186,002
차트 해석 방법

아래 차트는 Reshma Kewalramani에 의한 각 "공개 시장"(Open market)에서 계획되지 않은 거래 이후 증권의 주가 실적을 보여줍니다. 계획되지 않은 거래는 10b5-1 거래 계획의 일환으로 이루어지지 않은 거래입니다. 주가 실적은 주가의 누적 백분율 변화로 표시됩니다. 예를 들어, 2019년 1월 1일 내부자의 매매 거래가 이루어졌을 경우, 차트는 현재까지 증권의 일별 백분율 변화를 보여줍니다. 이 기간 동안 주가가 10달러에서 15달러로 간다면, 주가의 누적 백분율 변화는 50%가 됩니다. 10달러에서 20달러로의 가격 변화는 100%가 되며, 10달러에서 5달러로의 가격 변화는 -50%가 됩니다.

궁극적으로 내부자의 매매 거래가 내부자의 정보를 이용하여 이익을 얻기 위해 거래 타이밍을 맞추고 있는지 확인하기 위해 내부자의 매매 거래가 주가의 초과 수익률(양 또는 음)과 얼마나 밀접한 상관 관계가 있는지 확인하고자 합니다. 내부자가 이러한 작업을 수행하고 있는 상황을 고려해 보겠습니다. 이러한 상황에서 우리는 (a) 매입 후 양의 수익률 또는 (b) 매각 후 음의 수익률을 기대할 수 있습니다. (a)의 경우, 매입 차트는 상향으로 기울어진 일련의 곡선을 보여주며, 각 매입 거래 후 양의 수익률을 나타냅니다. (b)의 경우, SALE 차트는 하향으로 기울어진 일련의 곡선을 보여주며, 각 판매 거래 후 음의 수익률을 나타냅니다.

그러나 이것만으로는 결론을 도출하기에 충분하지 않습니다. 예를 들어, 해당 기업의 주가가 수년에 걸쳐 비주기적 상승 추세에 있다면, Fintel은 매입 후 도표가 모두 상향 곡선으로 예상할 수 있습니다. 마찬가지로, 수년에 걸쳐 비주기적 하락은 거래 후에 하향 곡선으로 초래할 가능성이 높습니다. 이 도표들 중 어느 것도 내부자의 매매 거래 활동을 시사하지는 않습니다.

가장 강력한 지표는 주가가 극단적으로 순환하는 상황일 것이고, PURCHASE 차트에는 긍정적인 시그널이, SALE 차트에는 부정적인 플롯이 존재했습니다. 이는 자신들의 금전적 이익을 위한 거래 타이밍을 재던 내부자에 의한 상황일 가능성이 높습니다.

내부자의 매매 거래 내역

아래 표는 증권거래위원회(SEC)에 공시된 Reshma Kewalramani의 내부자의 전체 거래 목록입니다.

보고일 거래일 보고 티커 증권 코드 10b5-1 지분 잔여 지분 변동률
(%)
지분
가치
거래
가치
잔여
가치
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,725 98,278 -1.72 496.95 -857,239 48,839,252
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5,995 100,003 -5.66 496.16 -2,974,479 49,617,488
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15,580 105,998 -12.81 495.38 -7,718,020 52,509,289
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,498 121,578 -2.80 494.33 -1,729,166 60,099,653
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,520 125,076 -1.97 493.29 -1,243,091 61,698,740
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -949 127,596 -0.74 491.30 -466,244 62,687,915
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,725 128,545 -2.08 490.54 -1,336,722 63,056,464
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -460 131,270 -0.35 489.32 -225,087 64,233,036
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,278 131,730 -2.43 488.27 -1,600,549 64,319,807
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,510 135,008 -1.83 487.13 -1,222,696 65,766,447
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -240 137,518 -0.17 482.84 -115,882 66,399,191
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -120 137,758 -0.09 481.50 -57,780 66,330,477
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 137,878 -0.29 479.75 -191,900 66,146,970
2026-02-26 2026-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -4,981 138,278 -3.48 485.11 -2,416,333 67,080,041
2026-02-19 2026-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -6,554 143,259 -4.37 483.75 -3,170,498 69,301,541
2026-02-19 2026-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 16,326 149,813 12.23
2026-02-18 2026-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -13,041 133,487 -8.90 487.76 -6,360,878 65,109,619
2026-02-12 2026-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8,297 146,528 -5.36 468.41 -3,886,398 68,635,180
2026-01-26 2026-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 11,885 154,825 8.31
2026-01-26 2026-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 26,972 142,940 23.26
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 5,710 115,968 5.18 389.95 2,226,614 45,221,722
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 4,290 110,258 4.05 389.08 1,669,153 42,899,183
2025-02-28 2025-02-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -14,079 105,915 -11.73 479.61 -6,752,429 50,797,893
2025-02-26 2025-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9,386 119,994 -7.25 483.28 -4,536,066 57,990,700
2025-02-19 2025-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -6,553 129,380 -4.82 463.46 -3,037,053 59,962,455
2025-02-14 2025-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 19,015 135,933 16.26
2025-02-12 2025-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8,300 116,918 -6.63 467.98 -3,884,234 54,715,286
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20,328 125,218 19.38
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29,118 104,890 38.43
2024-11-12 2024-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15,198 75,772 -16.71 515.00 -7,826,970 39,022,580
2024-08-01 2024-07-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15,202 90,970 -14.32 505.00 -7,677,010 45,939,850
2024-07-24 2024-07-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15,202 106,172 -12.52 497.00 -7,555,394 52,767,484
2024-06-14 2024-06-12 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 105,263 186,002 130.37
2024-05-29 2024-05-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,565 121,374 -1.27 457.00 -715,205 55,467,918
2024-05-29 2024-05-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1,565 122,939 1.29 187.53 293,484 23,054,751
2024-05-22 2024-05-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15,202 121,374 -11.13 447.00 -6,795,294 54,254,178
2024-02-27 2024-02-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9,386 136,507 -6.43 431.79 -4,052,781 58,942,358
2024-02-21 2024-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -7,019 145,893 -4.59 420.58 -2,952,051 61,359,678
2024-02-21 2024-02-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9,359 152,912 -5.77 424.01 -3,968,310 64,836,217
2024-02-13 2024-02-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8,255 162,271 -4.84 422.74 -3,489,719 68,598,443
2024-02-08 2024-02-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20,327 170,526 13.53
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 26,972 150,199 21.89
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 14,516 123,227 13.35
2023-12-19 2023-12-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -17,135 108,711 -13.62 407.00 -6,973,945 44,245,377
2023-12-19 2023-12-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 14,077 125,846 12.59 187.53 2,639,860 23,599,900
2023-12-19 2023-12-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3,058 111,769 2.81 155.57 475,733 17,387,903
2023-12-15 2023-12-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5,098 108,711 -4.48 397.00 -2,023,906 43,158,267
2023-11-15 2023-11-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5,097 113,809 -4.29 377.00 -1,921,569 42,905,993
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7,828 118,906 -6.18 355.00 -2,778,940 42,211,630
2023-05-01 2023-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -38 126,652 -0.03 340.19 -12,927 43,085,744
2023-05-01 2023-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,668 126,690 -1.30 339.43 -566,169 43,002,387
2023-05-01 2023-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,611 128,358 -1.24 338.69 -545,630 43,473,571
2023-02-28 2023-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9,386 129,969 -6.74 289.12 -2,713,680 37,576,637
2023-02-22 2023-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9,359 139,355 -6.29 292.85 -2,740,783 40,810,112
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -5,990 148,714 -3.87 298.26 -1,786,577 44,355,438
2023-02-14 2023-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3,372 154,704 -2.13 294.33 -992,481 45,534,028
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 26,972 158,076 20.57
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29,118 131,104 28.55
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12,388 101,986 13.83
2023-01-27 2023-01-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10,000 89,598 -10.04 315.05 -3,150,500 28,227,850
2022-11-10 2022-09-30 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 9,818 80,739 13.84
2022-08-17 2022-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11,689 99,598 -10.50 305.06 -3,565,846 30,383,366
2022-06-28 2022-06-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11,689 111,153 -9.52 291.30 -3,405,006 32,378,869
2022-06-13 2022-06-10 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
A - Award 70,921 70,921
2022-02-28 2022-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -7,246 122,842 -5.57 227.86 -1,651,074 27,990,778
2022-02-22 2022-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8,584 130,088 -6.19 232.51 -1,995,866 30,246,761
2022-02-14 2022-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3,031 138,672 -2.14 237.74 -720,590 32,967,881
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29,117 141,703 25.86
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29,032 112,586 34.75
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9,800 83,554 13.29
2021-11-23 2021-11-19 4 DNA Ginkgo Bioworks Holdings, Inc.
Restricted Stock Units
A - Award 9,818 9,818
2021-09-20 2021-09-16 4 DNA Ginkgo Bioworks Holdings, Inc.
Stock Option
A - Award 17,649 17,649
2021-09-20 2021-09-16 4 DNA Ginkgo Bioworks Holdings, Inc.
Stock Option
A - Award 51,782 51,782
2021-08-23 2021-08-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 4,243 73,754 6.10 196.34 833,071 14,480,860
2021-08-23 2021-08-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 5,757 69,511 9.03 195.14 1,123,421 13,564,377
2021-02-26 2021-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2,898 63,643 -4.36 217.57 -630,518 13,846,808
2021-02-19 2021-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2,080 66,541 -3.03 211.75 -440,440 14,090,057
2021-02-12 2021-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2,962 68,621 -4.14 214.16 -634,342 14,695,873
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29,031 71,583 68.22
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12,388 42,552 41.07
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3,516 30,164 13.19
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -509 3,058 -14.27
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1,564 15,642 -9.09
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -93 26,626 -0.35 273.27 -25,414 7,276,087
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -487 26,719 -1.79 272.76 -132,834 7,287,874
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -471 27,206 -1.70 271.42 -127,839 7,384,253
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -870 27,677 -3.05 270.36 -235,213 7,482,754
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -152 28,547 -0.53 269.11 -40,905 7,682,283
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 509 28,699 1.81 155.57 79,185 4,464,703
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1,564 28,190 5.87 187.53 293,297 5,286,471
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9 26,626 -0.03 288.37 -2,595 7,678,140
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -19 26,635 -0.07 287.63 -5,465 7,661,025
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -27 26,654 -0.10 286.07 -7,724 7,624,910
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10 26,681 -0.04 283.76 -2,838 7,571,001
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4 26,691 -0.01 282.74 -1,131 7,546,613
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6 26,695 -0.02 281.74 -1,690 7,521,049
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9 26,701 -0.03 280.47 -2,524 7,488,829
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7 26,710 -0.03 279.70 -1,958 7,470,787
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6 26,717 -0.02 276.40 -1,658 7,384,579
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2 26,723 -0.01 274.37 -549 7,331,990
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -510 3,567 -12.51
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1,564 17,206 -8.33
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -134 26,626 -0.50 275.17 -36,873 7,326,676
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -864 26,760 -3.13 274.04 -236,771 7,333,310
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -360 27,624 -1.29 272.77 -98,197 7,534,998
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 27,984 -1.06 271.92 -81,576 7,609,409
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -416 28,284 -1.45 270.35 -112,466 7,646,579
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 510 28,700 1.81 155.57 79,341 4,464,859
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1,564 28,190 5.87 187.53 293,297 5,286,471
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -111 26,626 -0.42 239.13 -26,543 6,367,075
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -420 26,737 -1.55 238.28 -100,078 6,370,892
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -320 27,157 -1.16 236.71 -75,747 6,428,333
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -340 27,477 -1.22 235.36 -80,022 6,466,987
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -660 27,817 -2.32 234.41 -154,711 6,520,583
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -440 28,477 -1.52 232.35 -102,234 6,616,631
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -450 28,917 -1.53 230.88 -103,896 6,676,357
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -893 29,367 -2.95 229.72 -205,140 6,746,187
2020-02-26 2020-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2,898 30,260 -8.74 239.23 -693,289 7,239,100
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -129 33,158 -0.39 245.75 -31,702 8,148,578
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -260 33,287 -0.78 244.94 -63,684 8,153,318
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -134 33,547 -0.40 243.76 -32,664 8,177,417
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -540 33,681 -1.58 242.62 -131,015 8,171,684
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -120 34,221 -0.35 241.71 -29,005 8,271,558
2020-02-19 2020-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -944 34,341 -2.68 241.50 -227,976 8,293,352
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -510 4,077 -11.12
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1,564 18,770 -7.69
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -129 35,285 -0.36 242.47 -31,279 8,555,554
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -271 35,414 -0.76 240.75 -65,243 8,525,920
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -423 35,685 -1.17 239.69 -101,389 8,553,338
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,251 36,108 -3.35 238.76 -298,689 8,621,146
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise -510 37,359 -1.35 155.57 -79,341 5,811,940
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise -1,564 36,849 -4.07 187.53 -293,297 6,910,293
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12,387 35,285 54.10
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9,800 22,898 74.82
2019-11-26 2019-11-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy)
M - Exercise -4,692 20,334 -18.75
2019-11-26 2019-11-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4,692 13,098 -26.37 219.37 -1,029,284 2,873,308
2019-11-26 2019-11-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4,692 17,790 35.82 187.53 879,891 3,336,159
2019-11-19 2019-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -61 13,098 -0.46 205.95 -12,563 2,697,533
2019-11-13 2019-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -509 4,587 -9.99
2019-11-13 2019-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -509 13,098 -3.74 199.00 -101,291 2,606,502
2019-11-13 2019-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 509 13,607 3.89 155.57 79,185 2,116,841
2019-10-31 2019-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -3,057 5,096 -37.50
2019-10-31 2019-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,057 13,098 -18.92 199.00 -608,343 2,606,502
2019-10-31 2019-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3,057 16,155 23.34 155.57 475,577 2,513,233
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -638 13,098 -4.64 189.00 -120,582 2,475,522
2019-05-17 2019-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -241 13,736 -1.72 165.41 -39,864 2,272,072
2019-02-21 2019-02-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 13,736 -0.72 188.49 -18,849 2,589,099
2019-02-21 2019-02-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -202 13,836 -1.44 187.27 -37,829 2,591,068
2019-02-21 2019-02-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,186 14,038 -7.79 186.75 -221,486 2,621,596
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 25,026 25,026
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9,799 15,224 180.63
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3,516 5,425 184.18
2018-10-09 2018-10-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,305 1,909 -54.70 186.95 -430,920 356,888
2018-04-02 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8,428
2018-04-02 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8,428
2018-04-02 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8,428
2018-04-02 3/A VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
4,214
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)